Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali

• Status: Completed
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Lymphatic filariasis is a public health problem in Mali. The existing data are not up to date and most of them are more than 15 years old. To address this issue in April 2000, the investigators started studies to update the epidemiology of lymphatic filariasis. There is no ongoing lymphatic filariasis control program in 2000 in Mali in terms of preventive chemotherapy treatment or vector control.

To fill these gaps, this current study aims to assess the impact of albendazole-ivermectin combination treatment on Wuchereria bancrofti infection and transmission in 6 rural highly endemic villages of Mali.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Centre d'Appui à la lutte contre la Maladie
• Collaborators: Malaria Research and Training Center, Bamako, Mali; World Health Organization
• Treatments: Albendazole; Ivermectin

Criteria

Inclusion Criteria:

• resident of the 6 villages

• 5 years and above

Exclusion Criteria:

• pregnant women

• breastfeeding women